Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 146 (2), 739-745
- https://doi.org/10.1016/0006-291x(87)90591-2
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast CarcinomaEndocrine Reviews, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Substituted-vinyl hydroxytriarylethylenes, 1-[4-[2-(diethylamino)ethoxy]phenyl]-1-(4-hydroxyphenyl)-2-phenylethylenes: synthesis and effects on MCF 7 breast cancer cell proliferationJournal of Medicinal Chemistry, 1986
- Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptorBiochemical and Biophysical Research Communications, 1986
- Induction of Epidermal Growth Factor-Related Polypeptides by 17β-Estradiol in MCF-7 Human Breast Cancer CellsEndocrinology, 1986
- Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7British Journal of Cancer, 1984
- Metabolism of clomiphene in the ratBiochemical Pharmacology, 1983
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- The effects of 17β estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined mediumEuropean Journal of Cancer (1965), 1980
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975